cigna glp-1 2025 will stop covering weight-loss drugs including Wegovy and Zepbound in its ​employee health plan effective July 1, according to Reuters December 2025 Policy Updates – Online Weight Loss Covered by

By acting on brain pathways involved in reward and impulse control, GLP-1s may help reduce the intensity and urgency of cravings across a range of addictive behaviors

Both engage central appetite circuits in the hypothalamus and hindbrain in research models, making them tools for probing satiety neurobiology and the durability of appetite suppression under sustained receptor activation

The following sgRNAs for GGT1 CRISPRi were used: sgGGT1 1 (HL-ID: 3) forward: 5-CACCGGTGCCTCCCACTGTCCGCCG-3

Main Citation "Your firm failed to exercise appropriate controls over computer or related systems..." "The FDA identified a deficiency where the firm failed to perform a 'full audit trail review of production equipment.'" 15 "Lack of automated audit trails, allowing selective reporting of results." 16 Detailed Analysis of the Violation Production Equipment Audit Trails: The firm failed to perform a "full audit trail review of production equipment".15 In modern aseptic filling lines, the equipment is controlled by a Human Machine Interface (HMI) or Supervisory Control and Data Acquisition (SCADA) system